Agrigenomics Market Demand Is Moving From Research Labs To Seed, Livestock, And Trait-Validation Pipelines
Agrigenomics refers to the application of genomics, molecular markers, DNA/RNA sequencing, genotyping, genome editing, bioinformatics, and marker-assisted selection in crop and livestock improvement. The market is estimated at USD 5.28 billion in 2026 and is projected to reach USD 11.72 billion by 2035, reflecting a 9.29% CAGR as seed companies, breeding programs, livestock genetics firms, food-security agencies, and research laboratories expand the use of genomic tools for yield improvement, disease resistance, climate tolerance, trait purity testing, and parent-line selection. Major segmentation in the Agrigenomics market includes sequencing platforms such as Illumina, PacBio, Sanger, and other NGS systems; objectives such as genotyping, DNA/RNA sequencing, gene expression profiling, marker-assisted selection, GMO/trait purity testing, and DNA extraction; and applications across cereals, oilseeds, fruits, vegetables, livestock, aquaculture, and plant genetic resource conservation.
Agrigenomics Demand Is Closest To Commercial Breeding, Not Standalone Laboratory Testing
The strongest demand for Agrigenomics comes from breeding cycles where a single season saved can change commercial seed economics. In crops such as corn, soybean, rice, wheat, cotton, canola, and vegetables, genomic testing is used to screen thousands of lines before field trials. This reduces the number of poor-performing lines entering multi-location trials, lowers field-testing cost, and improves the probability of identifying drought, salinity, pest-resistance, or yield-linked traits earlier.
The adoption base is clearest in commercial field crops. In the United States, genetically engineered crop adoption already covers a very high share of planted acreage, with herbicide-resistant soybean acreage reaching 96% in 2024 and GE corn also remaining dominant. This does not mean all acreage directly uses Agrigenomics services every year, but it indicates that seed procurement has already shifted toward trait-based, genetics-led decision-making. Once seed buyers accept trait value, upstream demand for genotyping, marker validation, genomic selection, and purity testing becomes more stable.
The crop segment is stronger than livestock in revenue intensity because seed companies run repeated breeding cycles, parental-line verification, hybrid development, and trait-stack validation across large trial populations. Livestock genomics is important in dairy, cattle, poultry, swine, and aquaculture, but testing frequency is more concentrated around breeding stock, elite herds, and parent lines rather than every production animal. As a result, livestock Agrigenomics demand is more value-per-sample driven, while crop Agrigenomics is more sample-volume driven.
Sequencing, Genotyping, And Marker-Assisted Selection Are The Core Revenue Pools
Among service objectives, genotyping and marker-assisted selection hold stronger commercial relevance than broad exploratory sequencing because buyers are usually solving defined breeding questions. A seed company does not always need full genome sequencing for every line; it often needs high-throughput SNP panels, trait markers, parentage confirmation, disease-resistance markers, and varietal identity checks at scale. This explains why array-based platforms and targeted sequencing remain important even as long-read sequencing improves.
Long-read sequencing is gaining relevance in complex traits, structural variation, pangenome development, and reference genome improvement. However, pricing still limits mass deployment in routine breeding pipelines. Short-read sequencing and SNP genotyping remain more cost-efficient for high-volume screening. The practical market split is therefore not “old sequencing versus new sequencing,” but discovery versus deployment: long-read and advanced sequencing support discovery, while genotyping panels and targeted assays support day-to-day commercial breeding.
Genome editing has added another demand layer. In September 2024, Corteva and Pairwise announced a five-year collaboration to develop gene-edited products across multiple crops, including traits linked to climate resilience. Such activity expands demand for target validation, off-target assessment, regulatory data packages, trait confirmation, and breeding integration. Agrigenomics suppliers benefit when gene editing moves beyond proof-of-concept and enters multi-crop development pipelines.
Rice, Corn, Soybean, And Specialty Crops Show Different Adoption Logic
Cereals and oilseeds dominate Agrigenomics demand because acreage, seed value, and breeding investment are high. Corn and soybean remain especially attractive because hybrid seed economics, trait stacking, and farmer willingness to pay for performance are already established. Rice is becoming more important because climate stress, salinity, and irrigation pressure are forcing public breeding systems to adopt genomic tools faster.
India’s May 2025 release of genome-edited rice varieties, including DRR Dhan 100 Kamala and Pusa DST Rice 1, shows how public-sector breeding can directly expand agrigenomic demand. DRR Dhan 100 was reported with 19% yield improvement, 20% lower greenhouse gas emissions, and potential irrigation water savings of 7,500 million cubic meters. Pusa DST Rice 1 was positioned for saline and alkaline soils with yield gains reported in the range of 9.66% to 30.4%. These numbers matter because rice is not a niche crop; it is a high-volume food-security crop where climate-resilient genetics can influence national seed systems.
Specialty crops such as berries, leafy greens, fruits, and vegetables are smaller by acreage but stronger in trait-value logic. Pairwise’s CRISPR food activity in North America shows that consumer-facing traits such as taste, bitterness reduction, nutrition, and convenience can create a different adoption path from commodity crops. In specialty crops, a successful trait can justify higher breeding cost because retail price per kilogram is much higher than bulk grains.
Supply Is Concentrated Around Sequencing Platforms, Bioinformatics, And Breeding-Integrated Service Providers
The Agrigenomics supply chain is organized around three groups: sequencing technology companies, contract genomics laboratories, and breeding-integrated seed or animal genetics companies. Illumina remains relevant because high-throughput short-read sequencing and arrays fit large sample volumes. PacBio and other long-read platforms are more relevant where structural variants, complex genomes, and reference-quality assemblies matter. Service providers compete on turnaround time, sample-preparation efficiency, data accuracy, bioinformatics interpretation, and ability to handle agricultural sample types such as leaf tissue, seed, blood, hair, semen, embryos, and microbial material.
Pricing pressure is strongest in routine genotyping. Large seed companies negotiate high-volume contracts, and public breeding institutions are cost-sensitive. In contrast, discovery sequencing, pangenome projects, complex trait analysis, and regulatory-grade validation carry higher pricing because they require deeper analysis, better bioinformatics, and stricter quality assurance.
The main challenge is not scientific acceptance; it is commercial conversion. Many farmers do not buy Agrigenomics directly. They buy seed, semen, breeding stock, or crop varieties whose development used genomics. This creates an indirect demand model where revenue depends on seed company budgets, public research funding, livestock breeding economics, and regulatory treatment of gene editing. Data interpretation is another constraint. Generating genomic data is easier than converting it into reliable phenotype prediction across weather, soil, management practice, and disease pressure. That is why the strongest suppliers are not only sequencing vendors; they are firms that can connect genomic markers with field performance and breeding decisions.
North America Leads Commercial Agrigenomics Adoption Because Seed And Livestock Genetics Are Already Data-Driven
North America remains the strongest commercial demand cluster for Agrigenomics because the region has a mature seed industry, large field-crop acreage, high livestock breeding intensity, and a strong installed base of genomic laboratories. The United States is the main demand country. Corn, soybean, cotton, dairy cattle, beef cattle, poultry, and swine breeding systems already use genomic selection, SNP genotyping, trait purity testing, parentage verification, and disease-resistance screening as routine decision tools.
The U.S. crop market gives Agrigenomics a direct commercial base. More than 90% of U.S. soybean, cotton, and corn acres are planted with genetically engineered seeds, and herbicide-tolerant soybean acreage reached 96% in 2024. This indicates that farmers already pay for genetic performance through seed pricing, while the upstream testing workload is concentrated among seed companies, trait developers, contract research organizations, and university breeding programs. Demand is not only from new trait discovery; it also comes from confirming seed purity, hybrid identity, germplasm ownership, and stacked-trait stability across production lots.
Canada is more livestock- and canola-oriented in its demand behavior. Dairy genomic evaluation, beef breeding programs, canola breeding, and cereal research support steady use of genotyping services. The service model is mostly contract-led: samples are collected by breeders, seed firms, universities, or animal genetics companies, then processed through regional or international genomic laboratories. The customer base is concentrated among commercial seed companies, animal breeding organizations, public research institutions, food-security agencies, and agricultural biotechnology firms.
China, India, And Japan Are Moving Agrigenomics Toward Food-Security And Public Breeding Programs
Asia Pacific is not a single demand pattern. China is supply-and-policy driven, India is public-breeding and food-security driven, while Japan has a high-precision research and specialty-crop orientation. China is one of the most important supply and demand countries because it has domestic sequencing capacity, large crop research budgets, and government interest in reducing grain import dependency. In December 2024, China approved five gene-edited crop varieties and 12 genetically modified soybean, corn, and cotton products, with safety certificates valid for five years from December 25, 2024. That approval pipeline directly increases demand for trait validation, regulatory molecular characterization, seed multiplication testing, and post-approval monitoring.
India is emerging as a high-volume public-sector market for crop genomics. The May 2025 launch of genome-edited rice varieties DRR Dhan 100 Kamala and Pusa DST Rice 1 by ICAR created a measurable adoption signal because rice is tied to food security, irrigation pressure, and climate resilience. Reported claims around 19% yield improvement, lower greenhouse gas emissions, and water-saving potential show why India’s Agrigenomics demand will be strongest in rice, pulses, oilseeds, wheat, millet, and climate-stress breeding rather than only premium private seed segments.
Japan’s market is smaller by acreage but stronger in technical intensity. The demand base includes universities, national research institutes, specialty crop breeders, livestock research groups, and precision agriculture programs. Japan is more likely to use high-value sequencing, gene expression profiling, and trait-specific molecular research than mass-volume field-crop genotyping.
Europe’s Agrigenomics Demand Is Strong In Research, But Regulation Shapes Commercial Adoption
Europe has a sophisticated agrigenomics supply base, but commercial crop deployment is more constrained than in North America or parts of Asia. Germany, France, the Netherlands, Denmark, Spain, and the United Kingdom are major demand countries because they combine seed research, livestock breeding, food traceability, public science funding, and advanced laboratory infrastructure. However, regulation remains a major filter between laboratory capability and seed-market adoption.
The European Parliament approved its position on New Genomic Techniques in February 2024, and the EU Council adopted new rules in April 2026 to create a framework for plants produced by certain new genomic techniques. This matters for Agrigenomics because regulatory clarity affects whether breeders invest in CRISPR-based crops, molecular characterization, trait validation, and regulatory data packages. Until adoption pathways become commercially predictable, Europe’s demand remains stronger in research services, animal breeding, seed quality testing, traceability, and public-sector genomics than in broad field deployment.
Europe is also a supply region. Eurofins Genomics, university-linked genomic centers, national crop institutes, and private laboratories provide plant, animal, and aquaculture genotyping services. The region is less dependent on imported services but remains dependent on global sequencing instruments, reagents, consumables, and bioinformatics platforms supplied by large life-science technology companies.
Service Delivery, Sourcing, And Procurement Are Built Around Sample Volume And Turnaround Time
Agrigenomics is a service-and-platform market rather than a conventional manufactured product market. The supply chain includes sample collection kits, DNA/RNA extraction reagents, sequencing instruments, microarrays, PCR systems, lab automation, cloud bioinformatics, and data interpretation. Procurement is usually project-based for research institutions and contract-based for seed and livestock companies.
Large buyers negotiate on price per sample, turnaround time, marker density, data accuracy, repeatability, and compatibility with breeding databases. Small public laboratories may buy instruments and reagents, while commercial breeders often outsource high-throughput work to specialist service providers. Import-export dependency is therefore not mainly about physical product shipments of Agrigenomics output; it is about imported sequencing instruments, chips, reagents, consumables, and software capability. Countries with limited genomic lab infrastructure send samples or digital data to regional service hubs, while countries with strong biotechnology clusters localize sequencing and genotyping.
Segmentation highlights:
- By application, crops account for the stronger sample-volume base because seed companies screen thousands of lines per breeding cycle.
- By technology, SNP genotyping and targeted sequencing are stronger in routine breeding because they offer lower cost per sample than whole-genome sequencing.
- By customer group, seed companies and animal breeding firms create repeat demand, while universities and public institutes create project-based demand.
- By geography, North America leads in commercial adoption, Asia Pacific is gaining through food-security and public breeding programs, and Europe remains research-intensive but regulation-sensitive.
One visible pricing trend is the gap between discovery and deployment. Whole-genome sequencing and long-read sequencing command higher pricing where structural variation, complex genomes, pangenomes, or reference assemblies are required. Routine SNP genotyping faces stronger price pressure because large breeding programs buy in volume and compare vendors on per-sample cost, lab automation, error rate, and turnaround time.
Competitive Structure Is Led By Platform Companies, Genotyping Service Providers, And Breeding-Integrated Players
The Agrigenomics competitive ecosystem is led by sequencing and microarray platform providers, genomic service laboratories, biotechnology companies, and breeding-integrated seed and animal genetics firms. Exact market share is not reliably disclosed across the full Agrigenomics value chain because many suppliers report broader life-science, diagnostics, animal safety, food safety, or sequencing revenue rather than a clean Agrigenomics line. Competitive position is therefore better assessed through technology reach, platform installed base, service capability, breeding integration, and regional customer access.
Illumina holds a strong position in high-throughput sequencing and microarray-based agricultural genotyping. Its Infinium and sequencing platforms are used in plant and animal genotyping, marker discovery, association studies, and genomic selection. The company’s advantage comes from installed base, ecosystem familiarity, array portfolio breadth, and compatibility with high-volume SNP screening. In routine crop and livestock applications, microarrays remain attractive because they provide repeatable marker panels at lower cost per sample than deep sequencing.
Thermo Fisher Scientific is another top-tier supplier through Applied Biosystems, Axiom microarrays, Ion Torrent sequencing, PCR systems, extraction workflows, and laboratory consumables. Its Axiom platform is positioned for plant, livestock, poultry, aquaculture, and companion animal genotyping. Thermo Fisher’s strength is breadth: it sells instruments, reagents, microarrays, sample-preparation products, and workflow tools, allowing customers to source multiple parts of the agricultural genomics workflow from one supplier.
Eurofins Genomics is important on the service side. Its offering includes genotyping, next-generation sequencing, DNA/RNA oligos, synthetic genes, and integrated project support for crop improvement, animal breeding, aquaculture genetics, and food production. The company’s advantage is contract-service scalability. It can serve small marker projects as well as high-throughput breeding programs without requiring the customer to own the full laboratory infrastructure.
Neogen is relevant mainly through the animal genomics and animal safety ecosystem. Its Animal Safety segment represented 28.7% of total revenue in fiscal 2025, showing the importance of animal-linked testing and diagnostics within its broader business. In livestock Agrigenomics, buyer needs include parentage testing, genomic evaluation, disease-risk screening, herd improvement, and breeding-stock selection. Neogen’s position is stronger where genomic information is linked with animal productivity, safety, and traceability.
Corteva, Bayer Crop Science, Syngenta, BASF, KWS, Limagrain, Pairwise, Benson Hill, and other crop-technology companies are not always pure-play Agrigenomics vendors, but they are central demand creators. Their breeding pipelines, trait discovery work, gene-editing programs, and seed commercialization strategies generate recurring demand for sequencing, genotyping, marker-assisted selection, trait validation, and regulatory molecular data. Corteva’s September 2024 joint venture with Pairwise is especially relevant because it links a major seed company with gene-editing capability across multiple crops and climate-resilience traits.
Regional and specialized service providers also matter. In India, genomics service companies, ICAR-linked institutions, and private agri-biotech laboratories support crop breeding, hybrid seed identification, QTL mapping, pathogen screening, and marker-assisted selection. In China, domestic sequencing capacity and national seed companies are increasingly important because regulatory approvals and food-security goals are pushing local capability. In Europe, service providers compete on compliance, data quality, traceability, and ability to serve public research and breeding customers.
Pricing behavior is split by buyer size and technical complexity. Large seed companies and livestock genetics firms pressure suppliers on per-sample genotyping cost, especially for routine SNP panels. Research projects involving whole-genome sequencing, long-read sequencing, pangenomes, or complex bioinformatics carry higher margins because they require deeper analysis and specialized interpretation. Reagent costs, sequencing-chip availability, automation investment, sample logistics, and bioinformatics labor remain the main cost drivers.
Recent developments shaping the Agrigenomics market:
- February 2024: The European Parliament backed a proposal on New Genomic Techniques, including separate treatment for certain NGT plants and restrictions around patents, creating a clearer policy route for crop innovation in the EU.
- September 2024: Corteva and Pairwise announced a five-year collaboration and joint venture to accelerate gene-edited products for climate-resilient agriculture across multiple crop traits.
- December 2024: China approved five gene-edited crop varieties and 12 GM soybean, corn, and cotton products, with five-year safety certificates, increasing regulatory demand for molecular testing and trait validation.
- May 2025: ICAR launched India’s first genome-edited rice varieties, DRR Dhan 100 Kamala and Pusa DST Rice 1, connecting Agrigenomics directly with rice yield, water-use efficiency, and climate-stress breeding.
- April 2026: The EU Council adopted rules on New Genomic Techniques, strengthening the policy basis for resilient crop development and future commercial genomics demand in Europe.
About Datavagyanik
Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.
Contact us:
Atul B (Sales Head)
Phone: +1 551 226 6002
Website: https://datavagyanik.com/
Email: sales@datavagyanik.com
